Overview
Mission
Program Staff
SAC Members
Employment
SRP Home Page
Contact Us
Application
CALL
Research Priorities
TEROC Strategies
Grant Adminstration
Manual, Reports & Forms
Funded Research
by Title
by Institution
by Investigator
by Award Cycle
by Award Type
by Subject Area
by Periodical
Advanced Search
Publications
Newsletters
Compendia
Annual Reports
TRDRP Conferences
News, Events & Links
News Briefs
Events Calendar
Related Links
Research by Grant Title
Title,
Institution
[
sort
]
Investigator
Award Cycle
Award
Ascertainment of environmental tobacco exposure in pregnancy
1999 (Cycle VIII)
$2,053,747
Sequoia Foundation
Martin Kharrazi
Ph.D.
Lowering Smoking & ETS Risks in Immigrant Pacific Rim Youth
1998 (Cycle VII)
$1,955,276
University of Southern California
C. Anderson Johnson
Ph.D.
Smoking during pregnancy: chromosome damage in newborns
1999 (Cycle VIII)
$1,662,871
Lawrence Livermore National Laboratory
James Tucker
Ph.D.
Quantitative Genetic Analysis
1998 (Cycle VII)
$1,490,600
SRI International
Dorit Carmelli
Ph.D.
School tobacco program and policy trial
1997 (Cycle VI)
$1,162,877
University of Southern California
Mary Ann Pentz
Ph.D.
Hyperactive nicotine receptors
2000 (Cycle IX)
$1,138,225
California Institute of Technology
Henry Lester
Ph.D.
Reducing Environmental Tobacco Smoke in Latino Children
1997 (Cycle VI)
$1,085,128
San Diego State University Research Foundation
Terry Conway
Ph.D.
Novel DNA vaccines for the treatment of lung cancer
2000 (Cycle IX)
$1,063,300
Scripps Research Institute
Ralph Reisfeld
Ph.D.
Maternal DNA repair of tobacco-induced sperm lesions
1998 (Cycle VII)
$1,046,880
Lawrence Livermore National Laboratory
Andrew Wyrobek
Ph.D.
Effect of tobacco smoke on leucocyte adhesion in vivo
2001 (Cycle X)
$1,023,946
La Jolla Institute for Molecular Medicine
Pragada Sriramarao
Ph.D.
Post-isoprenylation processing steps as anticancer targets
2000 (Cycle IX)
$1,017,450
J. David Gladstone Institutes
Stephen Young
M.D.
Smoking Cessation in Latinos Using Community Health Advisors
1997 (Cycle VI)
$992,121
San Diego State University Research Foundation
Gregory Talavera
M.D., M.P.H.
Mapping of Genetic Loci for Nicotine Dependence
1998 (Cycle VII)
$982,095
Ernest Gallo Clinic and Research Center
Kirk Wilhelmsen
M.D., Ph.D.
Nicotine replacement in school-based cessation
2000 (Cycle IX)
$961,266
University of Southern California
Clyde Dent
Ph.D.
Nicotine replacement in school-based cessation
2000 (Cycle IX)
$961,266
University of Southern California
Rita Leeseman
Mobilized dendritic cells for lung cancer
2000 (Cycle IX)
$950,821
Stanford University
Edgar Engleman
M.D.
Vascular targeting of lung tumors
1999 (Cycle VIII)
$899,686
Sidney Kimmel Cancer Center
Jan Schnitzer
M.D.
Stress and the use of nicotine
2000 (Cycle IX)
$897,484
Cedars-Sinai Medical Center
Robert Pechnick
Ph.D.
Tobacco-related disease in native California twins
1997 (Cycle VI)
$889,746
University of Southern California
Thomas Mack
M.D., M.P.H.
Family factors in smoking acquisition among Latino youth
1998 (Cycle VII)
$865,636
San Diego State University Research Foundation
Rafael Laniado-Laborin
M.D., MPH
Segregation Analysis of Tobacco Use in Families
1998 (Cycle VII)
$863,966
SRI International
Gary Swan
Ph.D.
Suppressor genes of lung cancer
1998 (Cycle VII)
$859,254
The Burnham Institute for Medical Research
Shi Huang
Ph.D.
Tobacco prevention/cessation at continuation schools
2002 (Cycle XI)
$848,679
University of Southern California
Steve Sussman
Ph.D.
Smoking and Risk of Proximal Vs. Distal Gastric Cancer
1994 (Cycle III)
$835,887
University of Southern California
Anna Wu
Ph.D.
Studies of novel antitumor agents for lung carcinoma
2000 (Cycle IX)
$833,491
University of California, San Diego
Michael Kelner
M.D., M.S.
Vascular targeting of lung tumors
2002 (Cycle XI)
$830,563
Sidney Kimmel Cancer Center
Jan Schnitzer
M.D.
Telephone Counseling for Pregnant Smokers
1999 (Cycle VIII)
$828,931
University of California, San Diego
Shu-Hong Zhu
Ph.D.
Culture and Tobacco Among American Indian Adolescents
2006 (Cycle XV)
$827,725
University of Southern California
Jennifer Unger
Ph.D.
Test of an internet virtual world for teen smoking cessation
2002 (Cycle XI)
$826,206
San Diego State University Research Foundation
Susan Woodruff
Ph.D.
Test of an internet virtual world for teen smoking cessation
2002 (Cycle XI)
$826,206
San Diego State University Research Foundation
James Crittenden
Tobacco use & acculturation: CA residents of Korean descent
2000 (Cycle IX)
$825,701
San Diego State University Research Foundation
Richard Hofstetter
Ph.D.
The effect of tobacco smoke on immune function in twins
1998 (Cycle VII)
$822,641
University of Southern California
Wendy Cozen
D.O., M.P.H.
p53 and p14ARF: Multiple pathways of lung cancer suppression
2002 (Cycle XI)
$821,050
Sidney Kimmel Cancer Center
Ruth Gjerset
Ph.D.
Impact of MPO in Tobacco-related Cardiovascular Disease
2007 (Cycle XVI)
$818,160
Sidney Kimmel Cancer Center
Wanda Reynolds
Ph.D.
Smoking, insulin resistance, and endothelial dysfunction
2003 (Cycle XII)
$814,989
Stanford University
Gerald Reaven
M.D.
The role of PARC in pulmonary inflammation
2004 (Cycle XIII)
$812,863
La Jolla Institute for Molecular Medicine
Ingrid Schraufstatter
M.D.
How does cigarette smoke induce cancer?
1997 (Cycle VI)
$811,518
Beckman Research Institute of the City of Hope
Gerd Pfeifer
Ph.D.
Novel nicotine cessation therapeutics
2000 (Cycle IX)
$802,840
Human BioMolecular Research Institute
John Cashman
Ph.D.
Social Context of Smoking in Adolescence and Young Adulthood
2007 (Cycle XVI)
$802,234
RAND Corporation
Joan Tucker
Ph.D.
Smoking-induced oxidant stress & platelet integrin alpha....
2001 (Cycle X)
$801,893
The Burnham Institute for Medical Research
Jeffrey Smith
Ph.D.
Nicotine-dependent recruitment of vascular progenitor cells
2006 (Cycle XV)
$799,907
The Burnham Institute for Medical Research
William Stallcup
Ph.D.
Determining how cholesterol-rich Lp(a) causes heart disease
1998 (Cycle VII)
$797,092
J. David Gladstone Institutes
Robert Pitas
Ph.D.
Por La Vida taking action for tobacco free communities
2000 (Cycle IX)
$795,633
University of California, San Diego
Ana Navarro
Ph.D.
Por La Vida taking action for tobacco free communities
2000 (Cycle IX)
$795,633
University of California, San Diego
Beatriz Barraza-Roppe
B.S.
Apolipoprotein E: remnant metabolism and atherogenesis
1999 (Cycle VIII)
$793,474
J. David Gladstone Institutes
Yadong Huang
M.D., Ph.D.
Does nicotine inhibit anticancer activities of Vitamin A?
1997 (Cycle VI)
$788,808
The Burnham Institute for Medical Research
Xiao-Kun Zhang
Ph.D.
Novel agents for apoptosis of lung cancer
2002 (Cycle XI)
$787,977
The Burnham Institute for Medical Research
Xiao-Kun Zhang
Ph.D.
Tobacco use & policies: San Diego Mexican American residents
2002 (Cycle XI)
$786,750
San Diego State University Research Foundation
Melbourne Hovell
Ph.D., M.P.H.
Novel DNA vaccines for the treatment of lung cancer
2003 (Cycle XII)
$783,900
Scripps Research Institute
Ralph Reisfeld
Ph.D.
Pathophysiology of abnormal remnant metabolism in smokers
2000 (Cycle IX)
$783,345
Palo Alto Medical Foundation Research Institute
Allen Cooper
M.D.
Unraveling lung cancer signaling pathways
2006 (Cycle XV)
$780,780
Scripps Research Institute
Jiing-Dwan Lee
Ph.D.
Integrins and drug resistance in small cell lung cancer
2003 (Cycle XII)
$780,144
The Burnham Institute for Medical Research
Kristiina Vuori
M.D., Ph.D.
Conformationally constrained nicotine vaccines
2005 (Cycle XIV)
$778,921
Scripps Research Institute
Kim Janda
Ph.D.
Telephone counseling for smokers using pharmacotherapy
2000 (Cycle IX)
$774,971
University of California, San Diego
Shu-Hong Zhu
Ph.D.
California AB13 compliance and ethnicity in urban bars
2003 (Cycle XII)
$769,266
Pacific Institute for Research and Evaluation
Roland Moore
BA, MA, Ph.D.
Nicotinic receptors, smoking and Parkinson's Disease
2002 (Cycle XI)
$765,971
Stanford University
Lorene Nelson
Ph.D.
Implementation of tobacco programs in Calif schools
2000 (Cycle IX)
$765,192
University of Southern California
Louise Rohrbach
Ph.D., M.P.H.
Effects of nicotine on fetal hematopoiesis
2007 (Cycle XVI)
$764,400
Torrey Pines Institute for Molecular Studies
Sophia Khaldoyanidi
M.D., Ph.D.
Modulating TLR9 Activation for Lung Cancer Therapy
2007 (Cycle XVI)
$762,411
Scripps Research Institute
Tsung-Hsien Chuang
Ph.D.
Tobacco smoke, inflammation & atherosclerosis
2001 (Cycle X)
$754,932
Scripps Research Institute
Linda Curtiss
Ph.D.
Expos children to secondhand smoke through cntaminated homes
2004 (Cycle XIII)
$754,504
San Diego State University Research Foundation
Georg Matt
Ph.D.
Effect of tobacco smoke on leukocyte adhesion in vivo
1998 (Cycle VII)
$754,361
La Jolla Institute for Molecular Medicine
Pragada Sriramarao
Ph.D.
Weight Gain as a Predictor of Smoking Relapse
1994 (Cycle III)
$750,320
SRI International
Marcia Ward
Ph.D.
Motivation-enhanced teenage tobacco use cessation
1997 (Cycle VI)
$750,248
University of Southern California
Steve Sussman
Ph.D.
Simple exposure indicators for ETS particles
2002 (Cycle XI)
$749,647
Lawrence Berkeley National Laboratory
Lara Gundel
Ph.D.
Roles of Hypoxia, Nicotine, & Camp in Ischemic Heart Failure
1995 (Cycle IV)
$746,727
SRI International
Keith Webster
Ph.D.
Sociocultural Determinants of Menthol Smoking Among Blacks
2006 (Cycle XV)
$746,567
Charles R. Drew University of Medicine & Science
Bruce Allen
DrPH
Developing treatments that lower blood cholesterol levels
1997 (Cycle VI)
$746,536
Scripps Research Institute
Linda Curtiss
Ph.D.
Novel strategy for protecting neurons from injury in stroke
1999 (Cycle VIII)
$742,809
Stanford University
Robert Sapolsky
Ph.D.
Neurobiological substrates of nicotine addiction
1998 (Cycle VII)
$742,393
Scripps Research Institute
Athina Markou
Ph.D.
Women and smoking: from adolescence to young adulthood
2004 (Cycle XIII)
$737,742
RAND Corporation
Phyllis Ellickson
Ph.D.
Antioxidants, cigarette smoking and atherosclerosis
1998 (Cycle VII)
$730,640
University of Southern California
James Dwyer
Ph.D.
Tobacco use and atherosclerosis protection by paraoxonase
2004 (Cycle XIII)
$729,234
Scripps Research Institute
Linda Curtiss
Ph.D.
Smoking, microsatellite instability & gastric cancers
2001 (Cycle X)
$729,199
University of Southern California
Anna Wu
Ph.D.
Environmental contexts of smoking for Southeast Asians
2004 (Cycle XIII)
$728,324
Pacific Institute for Research and Evaluation
Juliet Lee
BA, MA, PhD
IAP Antagonists for lung cancer treatment
2004 (Cycle XIII)
$727,658
The Burnham Institute for Medical Research
John Reed
M.D., Ph.D.
Detection of occult metastases in patients with lung cancer
1999 (Cycle VIII)
$723,842
University of Southern California
Richard Cote
M.D.
Neurobiological substrates of nicotine addiction
2003 (Cycle XII)
$723,613
Scripps Research Institute
Athina Markou
Ph.D.
Vapor-phase organics in ETS: dynamics and exposure
1998 (Cycle VII)
$722,775
Lawrence Berkeley National Laboratory
Alfred Hodgson
B.A.
Role of nicotine in neuro protection
1999 (Cycle VIII)
$722,263
The Parkinson's Institute
Maryka Quik
Ph.D.
Nicotine Self-Administration in an Animal Model
2008 (Cycle XVII)
$720,434
Scripps Research Institute
George Koob
Ph.D.
Mechanism of nicotine action in developing lung
2000 (Cycle IX)
$720,281
University of Southern California
Carol Wuenschell
Ph.D.
Towards gene therapy for tobacco-related vascular disease
1998 (Cycle VII)
$719,328
J. David Gladstone Institutes
David Dichek
M.D.
Dissemination of a smoking cessation program for in patients
1999 (Cycle VIII)
$710,621
Stanford University
C. Barr Taylor
M.D.
Macrophage function in atherosclerosis
2000 (Cycle IX)
$709,200
Scripps Research Institute
Linda Curtiss
Ph.D.
Toxic and irritant pollutants from aged secondhand smoke
2007 (Cycle XVI)
$704,901
Lawrence Berkeley National Laboratory
Hugo Destaillats
Ph.D.
Lipoprotein classes and susceptibility to atherosclerosis
1998 (Cycle VII)
$702,940
J. David Gladstone Institutes
Stephen Young
M.D.
Inflammation, innate immunity, TLRs, and atherosclerosis
2002 (Cycle XI)
$697,650
Scripps Research Institute
Peter Tobias
Ph.D.
Spanish tobacco-related disease self-management: evaluation
1997 (Cycle VI)
$693,751
Stanford University
Kate Lorig
Ph.D.
Determinants of Smoking Prevalence among Cambodian Americans
2007 (Cycle XVI)
$693,630
California State University, Long Beach Foundation
Robert Friis
Ph.D.
Determinants of Smoking Prevalence among Cambodian Americans
2007 (Cycle XVI)
$693,630
California State University, Long Beach Foundation
Kimthai Kuoch
ApoE isoforms, fatty acid metabolism and atherosclerosis
2001 (Cycle X)
$691,616
J. David Gladstone Institutes
Robert Pitas
Ph.D.
Quantification of population exposure to secondhand smoke
1997 (Cycle VI)
$686,858
Stanford University
Paul Switzer
Ph.D.
Dysregulation of VSMC signaling induced by nicotine
2001 (Cycle X)
$683,510
Stanford University
Philip Tsao
Ph.D.
Tobacco Alteration of TGF Beta3 Control of Palatogenesis
2002 (Cycle XI)
$680,175
University of Southern California
Charles Shuler
D.M.D, Ph.D.
Smoking prevention for Asian-American college students
2003 (Cycle XII)
$679,368
Veterans Medical Research Foundation
Mark Myers
Ph.D.
Proteins that Remove Atherogeneic Lipoproteins from Blood
1995 (Cycle IV)
$678,254
J. David Gladstone Institutes
Robert Pitas
Ph.D.
Oral clefts, smoking & variation toxin biotransformation
1997 (Cycle VI)
$677,128
Children's Hospital Oakland Research Institute
Edward Lammer
M.D.
Mechanisms by which tobacco accelerates atherosclerosis
1998 (Cycle VII)
$675,731
Stanford University
John Cooke
M.D., Ph.D.
Hyperactive nicotine receptors
2003 (Cycle XII)
$675,487
California Institute of Technology
Henry Lester
Ph.D.
Internet-enhanced proactive telephone counseling
2002 (Cycle XI)
$674,731
Veterans Medical Research Foundation
Leslie Lenert
M.D., M.S.
Gastroschisis: maternal smoking and genetic variation
2007 (Cycle XVI)
$673,269
Children's Hospital Oakland Research Institute
Edward Lammer
M.D.
Exposure to Secondhand Smoke: Effects of Proximity
2007 (Cycle XVI)
$672,582
Stanford University
Lynn Hildemann
Ph.D.
Comprehensive evaluation of the ischemic leg
2000 (Cycle IX)
$672,390
Stanford University
Dwight Nishimura
Ph.D.
Vitamin A derivatives as antagonists of nicotine effects
2004 (Cycle XIII)
$670,085
The Burnham Institute for Medical Research
Xiao-Kun Zhang
Ph.D.
Improved therapy of lung cancer
2000 (Cycle IX)
$668,814
California Pacific Medical Center Research Institute
Li-Xi Yang
M.D., Ph.D.
Improved chemoradiotherapy of lung cancer
2005 (Cycle XIV)
$661,920
California Pacific Medical Center Research Institute
Li-Xi Yang
M.D., Ph.D.
Negative effects of smoke on novel HDL mimetic therapies
2008 (Cycle XVII)
$661,125
Lawrence Berkeley National Laboratory
John Bielicki
Ph.D.
Nicotine self-administration in an animal model
2003 (Cycle XII)
$660,156
Scripps Research Institute
George Koob
Ph.D.
Therapies of muscle dysfunction in obstructive lung disease
1997 (Cycle VI)
$659,714
LA Biomedical Research Institute at Harbor-UCLA Medical Center
Richard Casaburi
M.D., Ph.D.
Smoking induced dopamine release: buproprion effects
2002 (Cycle XI)
$659,060
Brentwood Biomedical Research Institute
Arthur Brody
M.D.
Experimental evaluation of minors' access to tobacco
2000 (Cycle IX)
$655,347
San Diego State University Research Foundation
Hope Landrine
Ph.D.
Tobacco, Nitrosamines, Damage, Repair, Mutations, and Cancer
2008 (Cycle XVII)
$655,000
Beckman Research Institute of the City of Hope
Timothy O'Connor
Ph.D.
Analysis of the Hippo pathway in lung cancer
2008 (Cycle XVII)
$654,999
Beckman Research Institute of the City of Hope
Gerd Pfeifer
Ph.D.
SHS Exacerbates cerebral ischemia: endothelial mechanisms
2005 (Cycle XIV)
$654,854
Stanford University
John Cooke
M.D., Ph.D.
Pharmacogenetics of Smoking Cessation
2006 (Cycle XV)
$653,384
Stanford University
Greer Murphy
M.D., Ph.D.
NRT and paroxetine for smoking cessation
1997 (Cycle VI)
$646,916
Stanford University
Joel Killen
Ph.D.
Role of nicotine/nicotinic receptors in Parkinson's disease
1998 (Cycle VII)
$644,770
The Parkinson's Institute
Maryka Quik
Ph.D.
Molecular Dynamics & Regulation of Apo A-I's Conformation
2007 (Cycle XVI)
$644,293
Children's Hospital Oakland Research Institute
Michael Oda
Ph.D.
Effect of Tobacco on Rat Lung Alveolar Lining Liquid
1995 (Cycle IV)
$643,213
Lawrence Berkeley National Laboratory
Jacob Bastacky
M.D.
Mechanisms underlying diaphragm adaptations in emphysema
1998 (Cycle VII)
$642,624
Cedars-Sinai Medical Center
Mario Fournier
Ph.D.
Nicotine and cardiac vulnerability to fibrillation
2002 (Cycle XI)
$641,821
Cedars-Sinai Medical Center
Hrayr Karagueuzian
Ph.D.
Transdermal nicotine for smokers with schizophrenia
2001 (Cycle X)
$640,429
LA Biomedical Research Institute at Harbor-UCLA Medical Center
Michael Smith
M.D.
Reducing provision of tobacco to minors from social sources
1998 (Cycle VII)
$639,838
Stanford University
Stephen Fortmann
M.D.
Smoking and variation of cardiovascular disease genes
2002 (Cycle XI)
$635,131
Children's Hospital Oakland Research Institute
Edward Lammer
M.D.
Nicotinic receptors in nicotine addiction
2008 (Cycle XVII)
$634,779
California Institute of Technology
Henry Lester
Ph.D.
Indoor measurements of environmental tobacco smoke
1997 (Cycle VI)
$634,217
Lawrence Berkeley National Laboratory
Richard Sextro
Ph.D.
Anabolic therapies for muscle dysfunction in women with COPD
2001 (Cycle X)
$632,153
LA Biomedical Research Institute at Harbor-UCLA Medical Center
Richard Casaburi
M.D., Ph.D.
Neurobehavioral consequences of adolescent nicotine exposure
2001 (Cycle X)
$630,710
Scripps Research Institute
Cindy Ehlers
Ph.D.
ApoE related effect of smoking in cardiovascular disease
2008 (Cycle XVII)
$630,561
Children's Hospital Oakland Research Institute
Vasanthy Narayanaswami
Ph.D.
Understanding Nicotinic Receptor Subtype Specificity
2007 (Cycle XVI)
$630,295
California Institute of Technology
Dennis Dougherty
BS, MS, Ph.D.
Nicotine and congenital heart disease
2008 (Cycle XVII)
$629,797
Stanford University
Ching-Pin Chang
M.D., PH.D
Novel imaging methods for diagnosing tobacco related cancers
1997 (Cycle VI)
$629,087
Stanford University
Albert Macovski
Ph.D.
Role of passive smoke on sperm, ICSI and IVF
1998 (Cycle VII)
$628,862
University of California, San Diego
Hillary Klonoff-Cohen
Ph.D.
Heparan sulfate small molecules for contro tumor cell growth
2005 (Cycle XIV)
$626,807
California Institute of Technology
Linda Hsieh-Wilson
Ph.D.
Behavioral epidemiology of tobacco use among gay men
1998 (Cycle VII)
$626,433
University of California, San Francisco
Greg Greenwood
Ph.D.
Behavioral effects of neonatal nicotine exposure
2000 (Cycle IX)
$624,780
San Diego State University Research Foundation
Edward Riley
Ph.D.
Brain nAChR Occupancy: Effect of Secondhand Smoke
2007 (Cycle XVI)
$623,841
Brentwood Biomedical Research Institute
Arthur Brody
M.D.
Oral clefts, smoking & variation of toxin biotransformation
2004 (Cycle XIII)
$623,472
Children's Hospital Oakland Research Institute
Edward Lammer
M.D.
Geography of underage tobacco retail sales in Los Angeles
2003 (Cycle XII)
$622,260
Pacific Institute for Research and Evaluation
Robert Lipton
BA, MA, MPH, Ph.D.
Smokeless tobacco cessation among lumber mill employees
1997 (Cycle VI)
$620,213
University of Southern California
Clyde Dent
Ph.D.
Novel regulatory mechanisms for lung cancer growth
2001 (Cycle X)
$620,032
Veterans Medical Research Foundation
Randolph Hastings
M.D., Ph.D.
Role of oxidative stress and mitochondria in COPD
2008 (Cycle XVII)
$616,380
University of Southern California
Enrique Cadenas
Ph.D.
Vasoactive Mediators of Fetal Growth Retardation
1995 (Cycle IV)
$615,296
Cedars-Sinai Medical Center
Lony Castro
M.D.
Dissuading at-risk youth from smoking via mass media
2000 (Cycle IX)
$610,340
University of California, Irvine
Cornelia Pechmann
Ph.D.
Smoking Policies and Secondhand Smoke in Rental Cars
2006 (Cycle XV)
$609,853
San Diego State University Research Foundation
Georg Matt
Ph.D.
Effects of tobacco-induced gamete damage on embryogenesis
2004 (Cycle XIII)
$608,740
Lawrence Berkeley National Laboratory
Francesco Marchetti
Ph.D.
Nicotine-pathological angiogenesis and genetic determinants
2002 (Cycle XI)
$608,420
Stanford University
John Cooke
M.D., Ph.D.
-Heterologous Expression of Brain Nicotinic Acetylcholine Re
1995 (Cycle IV)
$598,774
California Institute of Technology
Henry Lester
Ph.D.
A novel approach to prevent in utero nicotine lung injury
2005 (Cycle XIV)
$597,916
LA Biomedical Research Institute at Harbor-UCLA Medical Center
Virender Rehan
M.D.
Human neurophysiology of nicotine analgesia: sex differences
2000 (Cycle IX)
$595,994
University of California, San Francisco
David Becker
Ph.D.
A dynamic model of smoking and healthcare expenditures in CA
2000 (Cycle IX)
$595,843
University of California, San Francisco
Wendy Max
Ph.D.
ETS effects on breathing patterns
2000 (Cycle IX)
$590,780
University of California, Davis
Jesse Joad
M.D.
Cytokine gene-modified dendritic cells for lung cancer
2000 (Cycle IX)
$590,523
University of California, Los Angeles
Steven Dubinett
M.D.
Smoking prevention for Asian-American college students
2001 (Cycle X)
$588,595
Veterans Medical Research Foundation
Mark Myers
Ph.D.
RCT of tobacco dependence treatment benefits in an HMO & PPO
2000 (Cycle IX)
$582,472
University of California, Berkeley
Helen Halpin
Ph.D.
A longitudinal study of smoking transitions in youth
1999 (Cycle VIII)
$577,574
University of California, San Diego
Elizabeth Gilpin
M.S.
Chronic nicotine treatment in primates; role of a6b2 nAChRs
2008 (Cycle XVII)
$577,128
The Parkinson's Institute
Maryka Quik
Ph.D.
Membrane Signaling Pathways of RAS/RAB Proteins
1995 (Cycle IV)
$574,559
Scripps Research Institute
William Balch
Ph.D.
DNA replication, regulation of the cell cycle, and cancer
2000 (Cycle IX)
$571,742
California Institute of Technology
Judith Campbell
Ph.D.
Expression of the Human apo-B Gene in Transgenic Mice
1995 (Cycle IV)
$569,759
Palo Alto Medical Foundation Research Institute
Beatriz Levy-Wilson
Ph.D.
Patterns of tobacco use from adolescence to young adulthood
1997 (Cycle VI)
$565,277
RAND Corporation
Phyllis Ellickson
Ph.D.
Effects of passive smoking and pregnancy
1999 (Cycle VIII)
$565,186
Lawrence Livermore National Laboratory
Kenneth Turteltaub
Ph.D.
A Novel Approach to Prevent in Utero Nicotine Lung Injury
2008 (Cycle XVII)
$564,957
LA Biomedical Research Institute at Harbor-UCLA Medical Center
Virender Rehan
M.D.
Classroom animation tobacco awareness program effectiveness
2004 (Cycle XIII)
$558,761
WestEd
Barbara Dietsch
Ph.D.
Classroom animation tobacco awareness program effectiveness
2004 (Cycle XIII)
$558,761
WestEd
Diane Schwartz
M.A.
The role of multiple genes in susceptibility to smoking
1997 (Cycle VI)
$557,829
Beckman Research Institute of the City of Hope
David Comings
M.D.
Oxidative stress and skeletal muscle dysfunction in COPD
2006 (Cycle XV)
$555,000
University of California, San Diego
Russell Richardson
Ph.D.
A stage-based scheduled smoking intervention for Chinese
2005 (Cycle XIV)
$554,500
University of California, San Francisco
Janice Tsoh
Ph.D.
Smoke-free bars: analysis of the response from Long Beach
1998 (Cycle VII)
$552,978
California State University, Long Beach Foundation
Robert Friis
Ph.D.
Keep me smokefree
1998 (Cycle VII)
$550,002
Education Training and Research Associates, Inc.
Carol D'Onofrio
DrPH
Human tryptase gene expression: role in COPD
2000 (Cycle IX)
$545,409
University of California, San Francisco
George Caughey
M.D.
Hmong smoking prevalence & tobacco uses
2001 (Cycle X)
$539,350
California State University, Fresno Foundation
Pao Fang
Hmong smoking prevalence & tobacco uses
2001 (Cycle X)
$539,350
California State University, Fresno Foundation
Vickie Krenz
Ph.D., M.S.P.H.
Internet health research center: smoking, Latinos, & the Web
2004 (Cycle XIII)
$535,096
University of California, San Francisco
Ricardo Munoz
Ph.D.
Smoking predictors in Mexican American youth
1997 (Cycle VI)
$534,603
University of San Francisco
Gerardo Marin
Ph.D.
A Smokeless Tobacco Cessation Program: High School Athletes
1995 (Cycle IV)
$533,923
University of California, San Francisco
Margaret Walsh
MS, EdD
Relationship of perceived risks and benefits to teen smoking
2005 (Cycle XIV)
$532,037
University of California, San Francisco
Bonnie Halpern-Felsher
Ph.D.
LDL pathophysiology and lipoprotein structure
2003 (Cycle XII)
$527,245
Children's Hospital Oakland Research Institute
Robert Ryan
Ph.D.
Integrin Cytoplasmic Domains and Ligand Affinity Modulation
1994 (Cycle III)
$522,649
Scripps Research Institute
Timothy O'Toole
Ph.D.
Effect of nicotine on bone marrow cells
2001 (Cycle X)
$520,381
La Jolla Institute for Molecular Medicine
Sophia Khaldoyanidi
M.D., Ph.D.
Spanish/English web site for smoking cessation trials
2001 (Cycle X)
$519,674
University of California, San Francisco
Ricardo Munoz
Ph.D.
Nicotine in the Brain
2000 (Cycle IX)
$518,966
University of California, San Diego
Darwin Berg
Ph.D.
Correlates of cigarette craving in acute nicotine withdrawal
2003 (Cycle XII)
$517,818
Brentwood Biomedical Research Institute
Richard Olmstead
Ph.D.
The role of hCDC4 regulation of cyclin E in lung cancer
2003 (Cycle XII)
$517,032
Sidney Kimmel Cancer Center
Charles Spruck
Ph.D.
Association of Outlet Density with Smoking and Pack Price
2008 (Cycle XVII)
$516,285
Stanford University
Lisa Henriksen
Ph.D.
Nicotine withdrawal, smoking & attention: an fMRI study
2001 (Cycle X)
$515,303
University of California, Los Angeles
Edythe London
Ph.D.
Immunopharmacotherapy as a treatment for nicotine addiction
2002 (Cycle XI)
$515,270
Scripps Research Institute
Kim Janda
Ph.D.
Effects of nicotine withdrawal on aviator performance
2001 (Cycle X)
$515,243
Stanford University
Jerome Yesavage
M.D.
Effect of maternal smoking on human placental development
2000 (Cycle IX)
$515,124
University of California, San Francisco
Susan Fisher
Ph.D.
Tobacco Control Digital Library
1999 (Cycle VIII)
$514,796
University of California, San Francisco
Karen Butter
M.L.
Parkinson's Disease: A Protective Effect of Smoking?
1999 (Cycle VIII)
$512,849
Stanford University
Lorene Nelson
Ph.D.
Role of Pneumocystis in COPD Progression
2005 (Cycle XIV)
$512,737
University of Southern California
Ahmet Baydur
M.D.
Protecting the "hood" against tobacco: cessation project
2003 (Cycle XII)
$512,200
University of California, San Francisco
Ruth Malone
Ph.D., R.N.
Protecting the "hood" against tobacco: cessation project
2003 (Cycle XII)
$512,200
University of California, San Francisco
Carol McGruder
B.A.
Novel Office-Based Device for Imaging Vocal Cord Cancer
2003 (Cycle XII)
$510,000
University of California, Irvine
Brian Wong
M.D., Ph.D.
Tobacco Industry Targeting of Older Persons
2007 (Cycle XVI)
$509,993
University of California, San Francisco
Ruth Malone
Ph.D., R.N.
Determinants of smoking among gay & lesbian youth
2000 (Cycle IX)
$509,771
University of California, San Francisco
Jay Paul
Ph.D.
Targeting Hypoxia-inducible Factor to Treat Lung Cancer
2003 (Cycle XII)
$509,490
The Burnham Institute for Medical Research
Siva Kolluri
Ph.D.
Cotinine Metabolism in Infants and Children
2006 (Cycle XV)
$509,473
University of California, San Francisco
Neal Benowitz
M.D.
Hypnosis for Smoking Relapse Prevention
2007 (Cycle XVI)
$509,353
University of California, San Francisco
Timothy Carmody
Ph.D.
Use of entertainment education on TV to deter youth smoking
2005 (Cycle XIV)
$509,320
University of California, Irvine
Cornelia Pechmann
Ph.D.
Reaching and Treating LGBT Smokers: The Internet and NRT
2006 (Cycle XV)
$509,201
University of California, San Francisco
Gary Humfleet
Ph.D.
Clinical Pharmacology of Tobacco Alkaloids
2006 (Cycle XV)
$508,848
University of California, San Francisco
Peyton Jacob
Ph.D.
Passive smoking, inflammatory markers and childhood asthma
2003 (Cycle XII)
$508,299
University of California, San Diego
Hillary Klonoff-Cohen
Ph.D.
Smoking Policies and Secondhand Smoke in Hotel Rooms
2008 (Cycle XVII)
$508,293
San Diego State University Research Foundation
Georg Matt
Ph.D.
School-based tobacco control programming for deaf/hh youth
2003 (Cycle XII)
$506,967
University of California, Los Angeles
Barbara Berman
Ph.D.
School-based tobacco control programming for deaf/hh youth
2003 (Cycle XII)
$506,967
University of California, Los Angeles
Debra Sue Guthmann
Ed..D.
Measuring prenatal tobacco exposure in newborn blood spots
2008 (Cycle XVII)
$506,927
Sequoia Foundation
Juan Yang
Ph.D.
Effect of maternal smoking on early human development
2003 (Cycle XII)
$505,975
University of California, San Francisco
Susan Fisher
Ph.D.
Therapy for muscle dysfunction in COPD: cellular adaptations
1998 (Cycle VII)
$502,904
Cedars-Sinai Medical Center
Michael Lewis
M.D.
Controlled study of withdrawal symptoms in teen smokers
2003 (Cycle XII)
$499,890
Stanford University
Joel Killen
Ph.D.
Natural history of tobacco addiction in adolescents
1998 (Cycle VII)
$499,505
University of California, San Francisco
Anna-Barbara Moscicki
M.D.
Two approaches to referral for smoking cessation treatment
2001 (Cycle X)
$496,836
University of California, Los Angeles
Scott Eliot Sherman
M.D., M.P.H.
Adolescent susceptibility to tobacco: a panel analysis
2001 (Cycle X)
$495,433
University of California, Irvine
Larry Jamner
Ph.D.
Determinants of Susceptibility to Oxidized Lipoproteins
1995 (Cycle IV)
$495,384
University of California, Los Angeles
Alan Fogelman
M.D.
Nicotine & behavioral regulation in adult ADHD
2005 (Cycle XIV)
$495,092
University of California, Irvine
Jean-G. Gehricke
Ph.D.
The impact of secondhand smoke exposure on COPD outcomes
2008 (Cycle XVII)
$492,890
University of California, San Francisco
Mark Eisner
M.D., M.P.H.
An athletic trainer mediated spit tobacco cessation program
1998 (Cycle VII)
$490,546
University of California, San Francisco
Margaret Walsh
MS, EdD
Effect of Maternal Smoking on Early Human Development
2006 (Cycle XV)
$489,025
University of California, San Francisco
Susan Fisher
Ph.D.
Passive Smoking: Role of Airways Reactivity in Infancy
1995 (Cycle IV)
$486,888
University of California, Berkeley
Ira Tager
M.D., M.P.H.
Hyperactive nicotine receptors
1997 (Cycle VI)
$486,158
California Institute of Technology
Henry Lester
Ph.D.
ETS Effects on airway development in the primate lung
1998 (Cycle VII)
$483,652
University of California, Davis
Kent Pinkerton
Ph.D.
Persistent smoking in bars: an ethnographic analysis
2001 (Cycle X)
$482,317
Pacific Institute for Research and Evaluation
Roland Moore
BA, MA, Ph.D.
High Resolution OCT for Early Airway Cancer Detection
2007 (Cycle XVI)
$480,636
University of California, Irvine
Matthew Brenner
M.D.
Low-Cost Contingency Management for Smoking Cessation
2008 (Cycle XVII)
$478,751
University of California, San Francisco
Timothy Carmody
Ph.D.
Smokefree Homes and Smoking Initiation in a National Sample
2008 (Cycle XVII)
$478,281
University of California, San Diego
John Pierce
Ph.D.
Bupropion for hospital-based smoking cessation
2003 (Cycle XII)
$478,065
University of California, San Francisco
Joel Simon
M.D., M.P.H.
Nonsmokers helping smokers and the role of culture
2004 (Cycle XIII)
$476,656
University of California, San Diego
Shu-Hong Zhu
Ph.D.
Analysis of California adolescent tobacco data
2001 (Cycle X)
$475,742
University of California, Los Angeles
William McCarthy
Ph.D.
Role of Smad protein in growth inhibition of tumor cells
2000 (Cycle IX)
$474,492
Lawrence Berkeley National Laboratory
Kunxin Luo
Ph.D.
Cigarette smoke alters lipoprotein & artery wall interaction
1997 (Cycle VI)
$472,876
University of California, Los Angeles
Alan Fogelman
M.D.
Effects of prenatal nicotine exposure on nicotinic receptors
2000 (Cycle IX)
$471,654
University of California, San Francisco
Peter Sargent
Ph.D.
Bupropion for smoking cessation
1998 (Cycle VII)
$471,154
University of California, San Francisco
Joel Simon
M.D., M.P.H.
Tobacco exposure in pregnant women in minority populations
2004 (Cycle XIII)
$469,727
Sequoia Foundation
Martin Kharrazi
Ph.D.
Diaphragm adaptations following treatment for emphysema
1997 (Cycle VI)
$469,400
Cedars-Sinai Medical Center
Michael Lewis
M.D.
Diabetes & tobacco exposure in So CA American Indians
2005 (Cycle XIV)
$468,390
University of California, San Diego
Deborah Morton
Ph.D.
Birth defects, smoking and host susceptibility
2003 (Cycle XII)
$466,200
March of Dimes Birth Defects Foundation
Suzan Carmichael
Ph.D.
Nicotine Metabolism in Families
1998 (Cycle VII)
$465,537
University of California, San Francisco
Neal Benowitz
M.D.
Carbon monoxide and the brain growth spurt
1998 (Cycle VII)
$464,268
University of California, Los Angeles
John Edmond
Ph.D.
Pager-assisted smoking cessation treatment
2002 (Cycle XI)
$463,689
University of California, San Francisco
Timothy Carmody
Ph.D.
Environmental tobacco smoke exposure & adult asthma
2001 (Cycle X)
$460,032
University of California, San Francisco
Mark Eisner
M.D., M.P.H.
Effects of nicotine on postinfarction cardiac remodeling
1998 (Cycle VII)
$459,799
University of California, San Diego
Francisco Villarreal
M.D., Ph.D.
Lung volume reduction surgery in an animal emphysema model
2000 (Cycle IX)
$456,336
University of California, Irvine
Matthew Brenner
M.D.
Adolescent Susceptibility to Tobacco: A Panel Analysis
1997 (Cycle VI)
$456,076
University of California, Irvine
Larry Jamner
Ph.D.
Predictors of Smoking in African American Adolescents
1997 (Cycle VI)
$455,536
University of California, San Francisco
Mark Alexander
Ph.D.
Fertility, smoking and early mammalian development
2001 (Cycle X)
$454,490
University of California, Riverside
Prudence Talbot
Ph.D.
Hemoglobin Conversion to Pro-Oxidants by Cigarette Smoke
1995 (Cycle IV)
$454,365
Lawrence Berkeley National Laboratory
Rolf Mehlhorn
Ph.D.
Novel therapy for pancreatic cancer
1997 (Cycle VI)
$452,332
University of California, Irvine
Hung Fan
Ph.D.
Fertility, smoking and early mammalian development
1997 (Cycle VI)
$452,243
University of California, Riverside
Prudence Talbot
Ph.D.
Serum cotinine levels and reproductive outcomes
1997 (Cycle VI)
$452,159
Public Health Institute
Martin Kharrazi
Ph.D.
Transdermal nicotine replacement for hospitalized smokers
1997 (Cycle VI)
$451,969
University of California, San Francisco
Joel Simon
M.D., M.P.H.
Spanish/English web site for smoking cessation trials
1998 (Cycle VII)
$450,400
University of California, San Francisco
Ricardo Munoz
Ph.D.
Effect of maternal smoking on human placental development
1997 (Cycle VI)
$450,000
University of California, San Francisco
Susan Fisher
Ph.D.
Effect of Smoking on Success Rate of In Vitro Fertilization
1995 (Cycle IV)
$449,805
University of California, San Diego
Hillary Klonoff-Cohen
Ph.D.
Smoking initiation among Chinese and Vietnames adolescents
1997 (Cycle VI)
$449,734
University of California, San Francisco
Celia Kaplan
DrPH
ETS exposures in the California Teachers Study cohort
1998 (Cycle VII)
$449,677
Public Health Institute
Peggy Reynolds
Ph.D.
Effects of environmental tobacco smoke on the artery wall
1998 (Cycle VII)
$449,673
University of California, Davis
John Rutledge
M.D.
Cardiovascular responses through spinal nicotinic receptors
2001 (Cycle X)
$448,941
University of California, San Diego
Palmer Taylor
Ph.D.
Reactivity of surface nicotine towards indoor ozone
2003 (Cycle XII)
$448,132
Lawrence Berkeley National Laboratory
Hugo Destaillats
Ph.D.
Does tobacco exposure delay conception?
2003 (Cycle XII)
$447,845
Sequoia Foundation
Michelle Pearl
Ph.D.
Inflammatory compounds:role in tobacco-related lung disease
1998 (Cycle VII)
$447,367
University of California, San Diego
Timothy Bigby
M.D.
ETS effects on pulmonary breathing patterns
1997 (Cycle VI)
$446,954
University of California, Davis
Jesse Joad
M.D.
Anti-Tobacco Programming: Reaching Deaf and Hard of Hearing
1997 (Cycle VI)
$446,947
University of California, Los Angeles
Barbara Berman
Ph.D.
Nicotine toxicity acting on cardiac neurons
1997 (Cycle VI)
$446,920
University of California, San Diego
Darwin Berg
Ph.D.
Electrophysiological Effects of Perinatal Nicotine Exposure
1995 (Cycle IV)
$446,225
Scripps Research Institute
Cindy Ehlers
Ph.D.
Molecular origins of ApoB atherogenic lipoproteins
2000 (Cycle IX)
$445,617
University of California, San Francisco
Robert Hamilton
Ph.D.
Smoking interventions in diverse LGBT communities
2002 (Cycle XI)
$445,068
Progressive Research & Training for Action
Brenda Crawford
Gene therapy for emphysema
1997 (Cycle VI)
$443,179
University of California, San Francisco
Francis Szoka
Ph.D.
Analysis of tobacco industry documents on scientific researc
2000 (Cycle IX)
$442,646
University of California, San Francisco
Lisa Bero
Ph.D.
Passive Smoking and Clara Cell Development in the Lungs
1995 (Cycle IV)
$442,317
University of California, Davis
Kent Pinkerton
Ph.D.
Environmental tobacco smoke and newborn lung development
1997 (Cycle VI)
$440,500
University of California, Davis
Kent Pinkerton
Ph.D.
Comprehensive Tobacco Policy Model
1997 (Cycle VI)
$439,963
University of California, Irvine
Tammy Tengs
Sc.D.
Clinical pharmacology of tobacco alkaloids
1998 (Cycle VII)
$439,882
University of California, San Francisco
Peyton Jacob
Ph.D.
Dissemination of the Rx for Change in Psychiatry Curriculum
2008 (Cycle XVII)
$439,283
University of California, San Francisco
Judith Prochaska
Ph.D., M.P.H.
Nicotonic receptors: role in addiction and reproduction
1997 (Cycle VI)
$437,480
Salk Institute for Biological Studies
Stephen Heinemann
Ph.D.
Nicotine May Affect Inflammation
1999 (Cycle VIII)
$435,425
University of California, San Francisco
Frederick Jia-Pei Miao
M.D., Ph.D.
Bispecific molecular therapy of small cell lung cancer
2001 (Cycle X)
$434,805
University of California, San Diego
Edward Ball
M.D.
Developmental Relationship between NK and T-Cell Lineages
1995 (Cycle IV)
$434,126
California Institute of Technology
Ellen Rothenberg
Ph.D.
The role of media in smoking initiation and cessation
1997 (Cycle VI)
$433,880
University of California, San Diego
David Burns
M.D.
Supplement to tobacco disease in twins
1999 (Cycle VIII)
$432,989
University of Southern California
Thomas Mack
M.D., M.P.H.
How does smoke activate mucin transcription in lung cells?
1998 (Cycle VII)
$432,415
University of California, San Francisco
Carol Basbaum
Ph.D.
Smoking treatment for substance abusing adolescents
1998 (Cycle VII)
$431,607
University of California, San Diego
Mark Myers
Ph.D.
Patterns of tobacco use from adolescence to young adulthood
2001 (Cycle X)
$431,132
RAND Corporation
Phyllis Ellickson
Ph.D.
Neurotransmitter systems and tobacco smoking
1999 (Cycle VIII)
$430,910
University of California, Los Angeles
Richard Olmstead
Ph.D.
Cardiovascular responses to nicotine
1997 (Cycle VI)
$430,843
University of California, San Diego
Palmer Taylor
Ph.D.
To identify Egr-1 target genes important in pulmonary diseas
2000 (Cycle IX)
$430,539
The Burnham Institute for Medical Research
Ian de Belle
Ph.D.
Smoking Cessation in Vietnamese: A Controlled Trial
1995 (Cycle IV)
$429,006
University of California, San Francisco
Steve McPhee
M.D.
Interactions of Moesin during platelet activation
1995 (Cycle IV)
$428,524
Stanford University
Heinz Furthmayr
M.D.
Tobacco oxidants and the ceramide path in lung cell death
1999 (Cycle VIII)
$427,613
University of California, Davis
Tzipora Goldkorn
BSc, MSc, Ph.D.
Context & consequenes of smoking in a blue-collar cohort
2005 (Cycle XIV)
$426,555
Pacific Institute for Research and Evaluation
Carol Cunradi
Ph.D., M.P.H.
Quantification of lung doses from inhaled tobacco smoke
1997 (Cycle VI)
$425,728
University of California, Irvine
Robert Phalen
Ph.D.
Role of thioredoxin in ETS-induced pulmonary airway injury
1998 (Cycle VII)
$425,665
University of California, Davis
Reen Wu
Ph.D.
Effectiveness of a large prenatal tobacco reduction program
2004 (Cycle XIII)
$425,181
Sequoia Foundation
Michelle Pearl
Ph.D.
Modeling sleep disturbance during nicotine withdrawal
2002 (Cycle XI)
$424,344
SRI International
Teresa Steininger
Ph.D.
Ethnic and gender variation in nicotine detoxification
2003 (Cycle XII)
$424,142
SRI International
Huijun Ring
Ph.D.
Environmental tobacco smoke effects on lung surfactant
1999 (Cycle VIII)
$423,216
University of California, Santa Barbara
Joseph Zasadzinski
Ph.D.
Ethnicity and school-level effect on CA student tobacco use
2004 (Cycle XIII)
$422,120
University of California, Los Angeles
William McCarthy
Ph.D.
Chemotherapeutic inhibition of polysialic acid biosynthesis
2003 (Cycle XII)
$420,781
University of California, Davis
Jacquelyn Gervay-Hague
Ph.D.
NF-kB mediated inflammation in tobacco-induced lung cancer
2006 (Cycle XV)
$420,000
University of California, San Diego
Michael Karin
Ph.D.
Epigenetic Regulation of Airway MUC gene expression by smoke
2007 (Cycle XVI)
$420,000
University of California, Davis
Reen Wu
Ph.D.
Nicotinic Manipulation of the Hippocampus
2007 (Cycle XVI)
$420,000
University of California, San Diego
Darwin Berg
Ph.D.
Protective function of VEGF on the development of emphysema
2003 (Cycle XII)
$420,000
University of California, San Diego
Kechun Tang
M.D., Ph.D.
Activation and detoxification of lung cancer carcinogens
2006 (Cycle XV)
$420,000
University of California, San Diego
Robert Tukey
Ph.D.
Use of existing data to dvlp new tobacco control strategies
2003 (Cycle XII)
$419,888
University of California, San Diego
Karen Messer
Ph.D.
Brain imaging in nicotine addiction
2002 (Cycle XI)
$419,881
University of California, Los Angeles
Desmond Smith
Ph.D.
Use of Existing Data to Develop Tobacco Control Strategies
2006 (Cycle XV)
$419,720
University of California, San Diego
Karen Messer
Ph.D.
Neurobiological substrates of nicotine addiction
2006 (Cycle XV)
$419,503
University of California, San Diego
Athina Markou
Ph.D.
Regulations of phase II genes by oxidation products
2005 (Cycle XIV)
$419,500
University of California, Merced
Henry Forman
Ph.D.
Immune Targeted Therapy for Lung Cancer
2006 (Cycle XV)
$419,500
University of California, Los Angeles
Sherven Sharma
Ph.D.
Molecular predictors of oral cancer development
2002 (Cycle XI)
$419,000
University of California, San Francisco
Richard Charles Jordan
D.D.S., Ph.D.
ETS Effects on Lung Surfactant
2005 (Cycle XIV)
$419,000
University of California, Santa Barbara
Joseph Zasadzinski
Ph.D.
Neuronal oxidative stress from mild carbon monoxide exposure
2005 (Cycle XIV)
$418,972
University of California, Los Angeles
John Edmond
Ph.D.
Tobacco smoke and airway remodeling in asthma
2003 (Cycle XII)
$418,951
University of California, San Diego
David Broide
M.B., Ch.B.
Effect of smoke and gender on bronchiolar injury and repair
2005 (Cycle XIV)
$418,207
University of California, Davis
Laura Van Winkle
Ph.D.
African Americans and Mentholated Cigarettes
1999 (Cycle VIII)
$417,968
Charles R. Drew University of Medicine & Science
Bruce Allen
DrPH
Chemokine-based therapy for lung cancer
2001 (Cycle X)
$416,940
University of California, Los Angeles
Sherven Sharma
Ph.D.
Irritant and pain-reducing effects of nicotine
1997 (Cycle VI)
$415,704
University of California, Davis
Earl Carstens
Ph.D.
The role of media in smoking initiation & cessation
2001 (Cycle X)
$414,203
University of California, San Diego
David Burns
M.D.
Effect of smoke and gender on bronchiolar injury and repair
2002 (Cycle XI)
$413,288
University of California, Davis
Laura Van Winkle
Ph.D.
Self-hypnosis for smoking cessation
2001 (Cycle X)
$413,119
University of California, San Francisco
Timothy Carmody
Ph.D.
Nicotine and Smoking Effects on Neuromuscular Development
1995 (Cycle IV)
$412,639
Cedars-Sinai Medical Center
Mario Fournier
Ph.D.
Nicotine & its metabolites: apoptosis in developing neurons
2000 (Cycle IX)
$412,200
Human BioMolecular Research Institute
Jun Zhang
Ph.D.
Effects of Outlet/Ad Density on Teen Smking and Brand Choice
2005 (Cycle XIV)
$410,979
Stanford University
Lisa Henriksen
Ph.D.
Sex differences in nicotine effects on inflammation
2006 (Cycle XV)
$410,570
University of California, San Francisco
Paul Green
Ph.D.
Smoking, Free Radicals, Antioxidants and Disease Prevention
1995 (Cycle IV)
$408,853
University of California, Berkeley
Lester Packer
Ph.D.
Corporate strategies: design, conduct, publication of resrch
2004 (Cycle XIII)
$407,567
University of California, San Francisco
Lisa Bero
Ph.D.
Mechanism of stress effects on weight in nicotine withdrawal
1998 (Cycle VII)
$407,019
University of California, San Francisco
Jon Levine
M.D., Ph.D.
Environmental tobacco smoke effects on lung surfactant
2002 (Cycle XI)
$406,444
University of California, Santa Barbara
Joseph Zasadzinski
Ph.D.
Genetic susceptibility to tobacco-induced lung cancer
1998 (Cycle VII)
$406,120
University of California, Los Angeles
Oliver Hankinson
Ph.D.
Role of protein phosphatase 2A in lung cancer
2002 (Cycle XI)
$405,795
University of California, San Diego
Gernot Walter
Ph.D.
Lung volume reduction surgery in an emphysema model
1997 (Cycle VI)
$404,139
University of California, Irvine
Matthew Brenner
M.D.
cGMP regulation of vascular smooth muscle differentiation
2005 (Cycle XIV)
$403,818
University of California, San Diego
Renate Pilz
M.D.
SAR Studies of Novel antitumor Agents for Lung Carcinomas
1995 (Cycle IV)
$403,338
University of California, San Diego
Michael Kelner
M.D., M.S.
Neurobiological substrates of nicotine addiction
2001 (Cycle X)
$402,852
Scripps Research Institute
Athina Markou
Ph.D.
Use of existing data to develop new tobacco control strategi
2000 (Cycle IX)
$402,610
University of California, San Diego
Elizabeth Gilpin
M.S.
Brain adaptations to chronic nicotine expsoure
1997 (Cycle VI)
$402,111
University of California, Irvine
Frances Leslie
Ph.D.
Remnant lipoproteins, apolipoprotein E4 and atherosclerosis
2001 (Cycle X)
$400,500
J. David Gladstone Institutes
Robert Raffai
Ph.D.
Developing new vaccines for lung cancer
1998 (Cycle VII)
$398,511
University of California, Los Angeles
Michael Roth
M.D.
Reducing minors' access to tobacco: project CHALK
1997 (Cycle VI)
$398,114
Public Health Foundation Enterprises, Inc.
Hope Landrine
Ph.D.
Mild carbon monoxide exposure impairs the inner ear
2005 (Cycle XIV)
$397,320
University of California, Los Angeles
Ivan Lopez
Ph.D.
Novel Extracellular Sulfatases and Smoke-induced Lung Cancer
2008 (Cycle XVII)
$394,380
University of California, San Francisco
Steven Rosen
Ph.D.
Cigarette smoke injures lung epithelium by activating nSMase
2008 (Cycle XVII)
$394,380
University of California, Davis
Tzipora Goldkorn
BSc, MSc, Ph.D.
Pharmacogenomics of New Generation Platinums in Lung Cancer
2008 (Cycle XVII)
$394,380
University of California, San Francisco
Kathleen Giacomini
Ph.D.
Clinical Pharmacology of Tobacco Alkaloids
1995 (Cycle IV)
$393,855
University of California, San Francisco
Peyton Jacob
Ph.D.
Preserving At Risk Tobacco Control Policy Resources
2008 (Cycle XVII)
$392,644
University of California, San Francisco
Karen Butter
M.L.
How do nic and cig smoke affect neural control of breathing?
2004 (Cycle XIII)
$392,620
University of California, Los Angeles
Xuesi Shao
M.D.
Fertility smoking and early mammalian development
2004 (Cycle XIII)
$392,451
University of California, Riverside
Prudence Talbot
Ph.D.
Preserving at-risk tobacco control policy resources
2004 (Cycle XIII)
$392,342
University of California, San Francisco
Karen Butter
M.L.
Mechanism of smoke-induced MUC5B gene expression
2001 (Cycle X)
$392,117
University of California, Davis
Reen Wu
Ph.D.
SHS enhances cough via plasticity of brainstem neurons
2004 (Cycle XIII)
$392,047
University of California, Davis
Jesse Joad
M.D.
Cardiac ion channels and tobacco-related disease
2002 (Cycle XI)
$389,983
University of California, Santa Barbara
Carol Vandenberg
Ph.D.
Does TGF-b modulate Metastasis of Small Cell Lung Carcinoma
1994 (Cycle III)
$389,719
University of California, San Francisco
Rik Derynck
Ph.D.
Preventing tobacco smoke diseases by network antioxidants
1997 (Cycle VI)
$388,714
University of California, Berkeley
Gladys Block
Ph.D.
Macrophage DAP12 pathway in emphysema
2007 (Cycle XVI)
$387,237
University of California, San Francisco
Laura Koth
M.D.
Hormone replacement therapy, smoking & lipoprotein oxidation
1998 (Cycle VII)
$385,808
Scripps Research Institute
Carole Banka
Ph.D.
Function and Regulation of the Retinoblastoma Protein
1995 (Cycle IV)
$385,031
University of California, San Diego
James Feramisco
Ph.D.
Role of protein phosphatase 2A in lung cancer
2005 (Cycle XIV)
$384,497
University of California, San Diego
Gernot Walter
Ph.D.
Environmental tobacco smoke and early atherosclerosis
1997 (Cycle VI)
$383,814
University of Southern California
Wendy Mack
Ph.D.
The role of nicotine receptors in nicotine dependence
1997 (Cycle VI)
$381,317
University of California, Irvine
Katumi Sumikawa
Ph.D.
COX-2 regulation of vaccination responses in lung cancer
2004 (Cycle XIII)
$379,362
University of California, Los Angeles
Steven Dubinett
M.D.
Nicotinic receptors and Parkinson's disease
2002 (Cycle XI)
$376,470
The Parkinson's Institute
Maryka Quik
Ph.D.
Role of viral-derived genes in lung cancer
1997 (Cycle VI)
$375,800
Sidney Kimmel Cancer Center
Francoise Mathieu-Daude
Ph.D.
The geography of tobacco related disease in California
2002 (Cycle XI)
$374,786
Pacific Institute for Research and Evaluation
Robert Lipton
BA, MA, MPH, Ph.D.
Effects of pro and anti-smoking cues in stores on craving
2004 (Cycle XIII)
$373,894
Stanford University
Lisa Henriksen
Ph.D.
Clinical pharmacology of tobacco alkaloids
2001 (Cycle X)
$373,408
University of California, San Francisco
Peyton Jacob
Ph.D.
Programmed cell death in cigarette-induced lung disease
1998 (Cycle VII)
$371,556
University of California, San Francisco
V. Courtney Broaddus
M.D.
Nicotine and cardiac vulnerability to fibrillation
1997 (Cycle VI)
$370,057
Cedars-Sinai Medical Center
Hrayr Karagueuzian
Ph.D.
Tobacco use among American Indian adolescents in California
2003 (Cycle XII)
$368,975
University of Southern California
Jennifer Unger
Ph.D.
Ethnic difference in cigarette smoking dynamics among youth
1999 (Cycle VIII)
$366,852
University of Southern California
Xinguang Chen
Ph.D.
Nicotine pharmacogenetics: influence of ethnicity
1997 (Cycle VI)
$366,244
LA Biomedical Research Institute at Harbor-UCLA Medical Center
Russell Poland
Ph.D.
Role of Protein Phosphatases in Lung Cancer
1995 (Cycle IV)
$363,234
University of Southern California
Axel Schonthal
Ph.D.
T-Cell Stimulating Antigen Genes in Tumor Cells
1994 (Cycle III)
$362,814
University of California, Berkeley
Nilabh Shastri
Ph.D.
Tobacco Control in Latino Communities
1997 (Cycle VI)
$362,153
San Diego State University Research Foundation
John Elder
Ph.D., M.P.H.
Mechanisms of targeted therapy resistance in lung cancer
2006 (Cycle XV)
$358,500
University of California, Los Angeles
Kostyantyn Krysan
Ph.D.
Calorigenic and Atherogenic Effects of Smoking and Nicotine
1995 (Cycle IV)
$357,492
University of California, San Francisco
Marc Hellerstein
M.D., Ph.D.
Effects of Tobacco Smoke on Mucin Production in Rat Airways
1995 (Cycle IV)
$356,400
University of California, San Francisco
Carol Basbaum
Ph.D.
Gene Markers for Hypertension
1995 (Cycle IV)
$356,151
University of California, San Francisco
Theodore Kurtz
M.D.
Vitronectin in Cardiovascular Disease
1995 (Cycle IV)
$352,644
Scripps Research Institute
Dietmar Seiffert
M.D.
Recruitment of leukocytes to atherosclerotic lesions in vivo
1997 (Cycle VI)
$352,405
University of California, San Diego
Daniel Steinberg
M.D., Ph.D.
Targeted blood clotting therapy for lung cancer
1999 (Cycle VIII)
$350,851
University of Southern California
Peisheng Hu
Ph.D.
Predicting and Reducing Cigarette Sales to Minors
1995 (Cycle IV)
$350,549
Public Health Foundation Enterprises, Inc.
Hope Landrine
Ph.D.
Virtual world internet chat room for teen smoking cessation
2000 (Cycle IX)
$350,007
San Diego State University Research Foundation
Susan Woodruff
Ph.D.
Virtual world internet chat room for teen smoking cessation
2000 (Cycle IX)
$350,007
San Diego State University Research Foundation
James Crittenden
Nicotine & Neuroendocrine Cell Signalling in Fetal Lung
1995 (Cycle IV)
$349,873
University of Southern California
Carol Wuenschell
Ph.D.
Suppression of Oncogenic Ras Mutations
1995 (Cycle IV)
$348,032
University of California, Berkeley
Jasper Rine
Ph.D.
Prevalence and Correlates of African American Tobacco Use
2006 (Cycle XV)
$347,737
San Diego State University Research Foundation
Hope Landrine
Ph.D.
Prevalence and Correlates of African American Tobacco Use
2006 (Cycle XV)
$347,737
San Diego State University Research Foundation
Scott Roesch
Ph.D.
Improving tobacco use assessment among youth via telephone
1997 (Cycle VI)
$347,440
University of California, Berkeley
Joel Moskowitz
Ph.D.
Tests of the tobacco industry's youth smoking prevention ads
2000 (Cycle IX)
$343,044
Stanford University
Stephen Fortmann
M.D.
Smoking cessation and medical care use/costs in a large HMO
2003 (Cycle XII)
$337,964
University of California, San Francisco
Hai-Yen Sung
Ph.D.
Prevalence and Correlates of African American Tobacco Use
2006 (Cycle XV)
$335,039
California Black Health Network
Denise Adams-Simms
MPH
Transport and disposition of nicotine in the human placenta
1998 (Cycle VII)
$333,108
University of California, San Francisco
Deanna Kroetz
Ph.D.
Brachial Vasoreactivity in Young Adult Smokers
1997 (Cycle VI)
$332,294
Osteoporosis Medical Center
Jacques Barth
M.D., Ph.D.
Vitamin E kinetics in smokers
1998 (Cycle VII)
$332,110
University of California, Davis
Maret Traber
Ph.D.
Mechanisms underlying modulations of respiration by nicotine
2001 (Cycle X)
$330,458
University of California, Los Angeles
Xuesi Shao
M.D.
Chronic bronchitis: pathology of mucin gene expression
2000 (Cycle IX)
$329,481
University of California, Davis
Walter Finkbeiner
M.D., Ph.D.
Model for surveillance of CA tobacco control policies
2001 (Cycle X)
$325,761
Pacific Institute for Research and Evaluation
Harold Holder
Ph.D.
Water pipe use, SHS exposure & home policy in Arab Americans
2005 (Cycle XIV)
$323,460
San Diego State University Research Foundation
Nada Kassem
Dr.P.H., MS, RN
Structure-Function Correlations for Ras p21 and its Mutants
1995 (Cycle IV)
$322,049
University of Southern California
Arieh Warshel
Ph.D.
Tobacco exposure & subclinical atherosclerosis in NIDDM
2000 (Cycle IX)
$321,363
University of Southern California
Wendy Mack
Ph.D.
Benzo[a]pyrene: Biogenetic Effects on Hepatocytes in Vitro
1995 (Cycle IV)
$321,199
University of California, San Diego
Hyam Leffert
M.D.
Fertility, Smoking, and Early Mammalian Development
1995 (Cycle IV)
$321,193
University of California, Riverside
Prudence Talbot
Ph.D.
Cellular Defects in Lung caused by Tobacco Smoke
1995 (Cycle IV)
$319,013
University of California, San Francisco
Alan Verkman
M.D., Ph.D.
Cigar use prevalence: social and media determinants
1997 (Cycle VI)
$318,750
San Diego State University Research Foundation
Joachim Reimann
Ph.D.
Smoking and the pathogenesis of macular degeneration
2001 (Cycle X)
$316,038
University of California, Santa Barbara
Lincoln Johnson
Ph.D.
Implementation of California AB 13: smoking ban in bars
1998 (Cycle VII)
$315,181
University of California, San Francisco
Lisa Bero
Ph.D.
Mechanisms of Atherogenesis:Role of Shear Stress & Tobacco
1994 (Cycle III)
$314,974
Stanford University
Gary Gibbons
M.D.
Identification on Tumors of Molecular Targets for NK Cells
1995 (Cycle IV)
$314,006
University of California, San Francisco
William Seaman
M.D.
Environmental influences on tobacco use amg AAPI communities
2004 (Cycle XIII)
$311,543
Assoc of Asian Pacific Community Health Organizations
Rod Lew
MPH
Scientific and Administrative Core
1998 (Cycle VII)
$311,057
University of Southern California
C. Anderson Johnson
Ph.D.
Development of a blood test for pancreatic cancer
1997 (Cycle VI)
$308,819
Stanford University
Anson Lowe
M.D.
Role of protein phosphatase 2A in lung cancer
1999 (Cycle VIII)
$307,522
University of California, San Diego
Gernot Walter
Ph.D.
Proteins involved in nicotine receptor clustering
2000 (Cycle IX)
$307,246
University of California, San Diego
William Conroy
Ph.D.
Studies of novel antitumor agents for lung cancers
1998 (Cycle VII)
$306,000
University of California, San Diego
Michael Kelner
M.D., M.S.
The Dopamine D2 Receptor in Nicotine Addiction
1995 (Cycle IV)
$304,790
City of Hope National Medical Center
David Comings
M.D.
Transcriptional Regulation of Programmed Cell Dealth
1995 (Cycle IV)
$304,418
University of California, Berkeley
Astar Winoto
Ph.D.
Nitrogen Oxides and cigarette smoke-induced injury
1998 (Cycle VII)
$304,118
University of California, Davis
Albert van der Vliet
Ph.D.
Effect of tobacco-related policy change on smoking behavior
2002 (Cycle XI)
$303,504
University of California, San Diego
David Burns
M.D.
Lesbian, gay, bisexual and transgender tobacco use
2004 (Cycle XIII)
$302,119
Kaiser Foundation Research Institute
Elisabeth Gruskin
DrPH
Susceptibility to smoking among adolescent never smokers
1998 (Cycle VII)
$301,356
University of Southern California
Jennifer Unger
Ph.D.
Tobacco GeneûEnvironment Interactions & Minority Asthmatics
2006 (Cycle XV)
$299,500
University of California, San Francisco
Shweta Choudhry
Ph.D.
Tobacco, acculturation and gastric cancer among Hispanics
2005 (Cycle XIV)
$298,996
University of California, Davis
Lesley Butler
Ph.D.
Smoking and lifestyle risk factors for premenstrual changes
1998 (Cycle VII)
$297,783
University of California, Davis
Ellen Gold
Ph.D.
Smoking, Personality and the Risk of Parkinson's Disease
1995 (Cycle IV)
$297,245
Kaiser Foundation Research Institute
Stephen Van Den Eeden
Ph.D.
The role of P450s in tobacco-mediated lung cancer
2001 (Cycle X)
$295,815
California Toxicology Research Institute
Scott Allen
M.S., Ph.D.
Electrophysiological Effects of Perinatal Nicotine Exposure
1995 (Cycle IV)
$293,752
San Diego State University Research Foundation
Edward Riley
Ph.D.
Role of integrins in cardiac innervation and function
2000 (Cycle IX)
$293,277
University of California, Santa Barbara
Dennis Clegg
Ph.D.
Cigar smoking among young adults: formative research
1997 (Cycle VI)
$292,920
California State University, Long Beach Foundation
Fen Rhodes
Ph.D.
Case studies of indoor air regulations: role of research
1997 (Cycle VI)
$292,210
University of California, San Francisco
Lisa Bero
Ph.D.
Engineering Salmonella for lung cancer therapy
2007 (Cycle XVI)
$291,600
Sidney Kimmel Cancer Center
Nabil Arrach
Ph.D.
Interaction of LDL receptor family members with ligands
2008 (Cycle XVII)
$291,600
Children's Hospital Oakland Research Institute
Taichi Yamamoto
Ph.D.
Modeling ETS Exposure and Dose Using PDA E-Diaries
2006 (Cycle XV)
$291,531
San Diego State University Research Foundation
Marilyn Johnson-Kozlow
Ph.D.
Do receptors mediate the effects of nicotine on anxiety?
2005 (Cycle XIV)
$291,060
Salk Institute for Biological Studies
Tammy Booker
Ph.D.
Smoking and virulence of periodontal pathogens
2001 (Cycle X)
$289,574
Loma Linda University
Hansel Fletcher
Ph.D.
Expressing & Cloning of ATP-Sensitive Potassium Channels
1995 (Cycle IV)
$286,163
University of California, Santa Barbara
Carol Vandenberg
Ph.D.
Lifetime passive smoke exposure and breast cancer in the CTS
2004 (Cycle XIII)
$285,300
Northern California Cancer Center
Peggy Reynolds
Ph.D.
African Americans: NRT or Alternative Medicine for Cessation
2006 (Cycle XV)
$285,000
University of California, San Francisco
Valerie Yerger
ND, MA
Skeletal muscle structure and function in mice lacking VEGF
2005 (Cycle XIV)
$284,500
University of California, San Diego
Ivan Olfert
Ph.D.
Genetics and Impulsivity in Smoking Initiation
2008 (Cycle XVII)
$283,612
Veterans Medical Research Foundation
Neal Doran
Ph.D.
Effects of environmental tobacco smoke on pulmonary allergy
1998 (Cycle VII)
$282,568
University of California, Davis
Laurel Gershwin
D.V.M., Ph.D.
Motivational interviewing to prevent postpartum relapse
1997 (Cycle VI)
$282,502
Kaiser Foundation Research Institute
Virginia Quinn
MPH
Simple Exposure Indicators for Secondhand Tobacco Smoke
2006 (Cycle XV)
$280,818
Lawrence Berkeley National Laboratory
Lara Gundel
Ph.D.
Global determinants of tobacco use onset in diverse youth
1998 (Cycle VII)
$280,749
Education Training and Research Associates, Inc.
Scott Carvajal
Ph.D., MPH
Disproportionate cost of smoking for communities of color
2004 (Cycle XIII)
$278,980
University of California, San Francisco
Wendy Max
Ph.D.
Control of Mucociliary Clearance in the Respiratory Tract
1995 (Cycle IV)
$276,780
University of California, Los Angeles
Ellen Dirksen
Ph.D.
Tobacco-related cancer prevention by Vitamin A derivatives
1997 (Cycle VI)
$274,488
SRI International
Marcia Dawson
Ph.D.
Effectiveness of two different regimens in smoking clinic
1999 (Cycle VIII)
$272,989
University of California, Los Angeles
Scott Eliot Sherman
M.D., M.P.H.
Addressing Substance Abusers Who Also Smoke
1994 (Cycle III)
$270,931
Northern California Institute for Research & Education
Karen Sees
D.O.
Economic Analysis of Smoking Cessation Therapies
1999 (Cycle VIII)
$270,206
University of California, San Francisco
James Milton Lightwood
Ph.D.
Targeting the epithelial-mesenchymal transition in HNSCC
2007 (Cycle XVI)
$270,000
University of California, Los Angeles
Maie St. John
MD, PhD
Transcription Regulation of Inflammation by Glucocorticoids
2008 (Cycle XVII)
$270,000
University of California, Berkeley
Jen-Chywan Wang
Ph.D
Community and Family Context of Teen Smoking
2008 (Cycle XVII)
$270,000
University of California, Los Angeles
Ritesh Mistry
Ph.D. M.P.A.
Secondhand Smoke and Nontuberculous Mycobacterial Infection
2007 (Cycle XVI)
$270,000
University of California, San Diego
Phung Lam
Ph.D.
Influences that promote ethnic disparities in smoking
2003 (Cycle XII)
$269,971
University of California, San Diego
Dennis Trinidad
Ph.D., M.P.H.
Smoking-related changes in LDL and atherosclerosis
2003 (Cycle XII)
$269,500
University of California, San Diego
Yury Miller
M.D., Ph.D.
Stem cell regeneration of the airway: effects of smoke
2006 (Cycle XV)
$269,500
University of California, Davis
Philip Thai
M.D.
Curriculum for treating nicotine dependence in psychiatry
2004 (Cycle XIII)
$269,243
University of California, San Francisco
Judith Prochaska
Ph.D., M.P.H.
Tobacco Industry Political Strategies After the 1998 MSA
2006 (Cycle XV)
$269,000
University of California, San Francisco
Dorothy Apollonio
Ph.D.
Tobacco industry use of diet and obesity issues
2004 (Cycle XIII)
$267,526
University of California, San Francisco
Elizabeth Smith
Ph.D.
Enzymatic targets for anticancer therapy
2002 (Cycle XI)
$267,304
J. David Gladstone Institutes
Martin Bergo
M.D., Ph.D.
Peripheral mechanisms of oral cancer pain in a mouse model
2003 (Cycle XII)
$265,332
University of California, San Francisco
Brian Schmidt
DDS, MD, PhD
Hormones and Tobacco: Joint Effects on Reproduction
1994 (Cycle III)
$263,611
Public Health Institute
Shanna Swan
Ph.D.
Molecular neurobiology of nicotine addiction
2001 (Cycle X)
$263,298
University of California, Los Angeles
Jim Boulter
Ph.D.
How does cardiac fuel metabolism influence heart disease?
1998 (Cycle VII)
$262,005
J. David Gladstone Institutes
Murielle Marie Veniant
Ph.D.
Effect of tobacco related policy change on smoking behavior
1999 (Cycle VIII)
$261,672
University of California, San Diego
David Burns
M.D.
A Methodological Multi-Ethnic Study of Smoking Initiation
1995 (Cycle IV)
$260,978
University of California, Los Angeles
Celia Kaplan
DrPH
Human oocyte development and PAH exposure
2005 (Cycle XIV)
$260,944
University of California, San Francisco
Renee Reijo Pera
Ph.D.
Predictors of Cigarette Smoking in Latino Adolescents
1997 (Cycle VI)
$260,674
University of San Francisco
Gerardo Marin
Ph.D.
Oxylipin Mediators Prevent Smoke-Induced Lung Inflammation
2007 (Cycle XVI)
$260,203
University of California, Davis
Ayala Luria
Ph.D.
NMR Study of 13C Edatrexate Metabolism
1995 (Cycle IV)
$258,990
University of California, Davis
Thomas Jue
Ph.D.
Effects of Environmental Tobacco Smoke on Pulmonary Allergy
1995 (Cycle IV)
$256,805
University of California, Davis
Laurel Gershwin
D.V.M., Ph.D.
Cloning & Expression of the Apo-B mRNA Editing Factor
1994 (Cycle III)
$254,743
J. David Gladstone Institutes
Thomas Innerarity
Ph.D.
Brain metabolic changes with cigarette craving
1998 (Cycle VII)
$250,850
Brentwood Biomedical Research Institute
Arthur Brody
M.D.
Developing policy to reverse cigar trend: roles of media
1997 (Cycle VI)
$249,785
University of California, San Francisco
Lisa Bero
Ph.D.
Analysis of a lung tumor supressor gene at 3p21.3
2001 (Cycle X)
$249,438
Beckman Research Institute of the City of Hope
Gerd Pfeifer
Ph.D.
Tobacco use and cessation among drug users
1998 (Cycle VII)
$249,392
University of California, Los Angeles
Yih-Ing Hser
Ph.D.
Inheritance and Smoking in Urinary Tract & Pancreas Cancer
1995 (Cycle IV)
$248,283
University of Southern California
Thomas Mack
M.D., M.P.H.
Hormone replacement therapy, smoking & lipoprotein oxidation
1998 (Cycle VII)
$245,584
La Jolla Institute for Molecular Medicine
Carole Banka
Ph.D.
Effects of Legislation on ETS Exposure in California
1997 (Cycle VI)
$245,189
University of California, San Diego
Arthur Farkas
Ph.D.
Acculturation & cigarette smoking among Asian-Americans
1997 (Cycle VI)
$244,715
University of Southern California
Xinguang Chen
Ph.D.
Nicotine pharmacogenetics: influence of ethnicity
1997 (Cycle VI)
$242,344
Cedars-Sinai Medical Center
Russell Poland
Ph.D.
Evaluation of office ETS exposure in relation to AB 13
1999 (Cycle VIII)
$242,063
Public Health Institute
Leon Alevantis
M.S.
Functional Antagonists of Nicotine
1995 (Cycle IV)
$236,936
Northern California Institute for Research & Education
S. Paul Berger
M.D.
Aggression and Nicotine
1997 (Cycle VI)
$230,326
University of California, Irvine
Larry Jamner
Ph.D.
Irritant and analgesic effects of nicotine
2002 (Cycle XI)
$226,650
University of California, Davis
Earl Carstens
Ph.D.
New therapy for lung cancer using radioiodide
2000 (Cycle IX)
$225,000
University of California, Los Angeles
Min Huang
M.D., M.S.
Carbon monoxide as a modulator of myocardial function
1999 (Cycle VIII)
$225,000
University of California, Davis
Ulrike Kreutzer
Ph.D.
Smoking & depression in Chinese vs. non-Chinese
1999 (Cycle VIII)
$225,000
University of California, San Francisco
Janice Tsoh
Ph.D.
Regulation of lung inflammation by the LTC4 synthase pathway
1999 (Cycle VIII)
$225,000
University of California, San Diego
Kenneth Serio
M.D.
Neuroendocrine responses to nicotine: a physiologic probe
1998 (Cycle VII)
$225,000
University of California, San Francisco
Lori Karan
M.D.
Lung cancer therapy with in vivo-generated dendritic cells
2001 (Cycle X)
$225,000
University of California, Los Angeles
Saroj Basak
Pathways of catabolism of oxidized phospholipids
2001 (Cycle X)
$225,000
University of California, San Diego
Peter Friedman
Ph.D.
Involvement of PI3K pathway in bladder cancer invasion
2002 (Cycle XI)
$224,984
University of California, Davis
Colleen Sweeney
Ph.D.
Nicotinic receptors & synaptic aging
2001 (Cycle X)
$224,973
University of California, San Diego
Jay Coggan
Ph.D.
The biological basis of nicotine addiction
1997 (Cycle VI)
$224,949
University of California, Riverside
Bruce Cohen
Ph.D.
Prospective relationship between risk perception & teen toba
2000 (Cycle IX)
$224,884
University of California, San Francisco
Bonnie Halpern-Felsher
Ph.D.
Skeletal muscle structure and function in COPD
1999 (Cycle VIII)
$224,842
University of California, San Diego
Timothy Gavin
Ph.D.
Gene Augmentation Therapy for Tobacco Induced Emphysema
1995 (Cycle IV)
$224,786
University of California, Davis
Robert Malone
M.D.
COPD: oxygen transport and metabolism in skeletal muscle
2001 (Cycle X)
$224,500
University of California, San Diego
Luke Haseler
Ph.D.
Vascular endothelial growth factor receptor signaling
2000 (Cycle IX)
$224,500
University of California, San Francisco
Timothy Quinn
M.D.
Predictors of adolescent smoking initiation and cessation
1998 (Cycle VII)
$224,374
University of California, San Diego
Won Choi
Ph.D.
Activation of NF-kB by cigarette smoke
1999 (Cycle VIII)
$224,217
University of California, Davis
Richart Harper
M.D.
Effects of tobacco on inflammatory cell responses
1997 (Cycle VI)
$223,585
University of California, Davis
Lisa Miller
Ph.D.
Interdependence - smoking behavior & mood in natural setting
1997 (Cycle VI)
$222,843
University of California, Los Angeles
Richard Olmstead
Ph.D.
An economic analysis of factors influencing teen smoking
1998 (Cycle VII)
$221,497
University of California, San Diego
Sherry Emery
MBA, Ph.D.
Alterations in gene expression after tobacco smoke exposure
1997 (Cycle VI)
$216,612
University of California, Davis
Ken Yoneda
M.D.
Economic Impact of Secondhand Smoke for Communities of Color
2007 (Cycle XVI)
$216,038
University of California, San Francisco
Wendy Max
Ph.D.
Effect of sidestream smoke on lung injury and repair
1997 (Cycle VI)
$214,070
University of California, Davis
Laura Van Winkle
Ph.D.
50000 Fold Signal Enhancement for Imaging Vulnerable Plaque
2007 (Cycle XVI)
$213,845
Huntington Medical Research Institute
Pratip Bhattacharya
Ph.D.
Acculturation, media, peers, parents and adolescent smoking
1998 (Cycle VII)
$213,511
University of Southern California
Jennifer Unger
Ph.D.
p53 Mutations in Sporadic & Familial Childhood Tumors
1994 (Cycle III)
$213,407
University of California, Davis
Sara Bodner
M.D.
Expression of the Human apo-B Gene in Transgenic Mice
1995 (Cycle IV)
$211,090
J. David Gladstone Institutes
Beatriz Levy-Wilson
Ph.D.
Deposition of inhaled carcinogens in ETS
2001 (Cycle X)
$210,446
University of California, Irvine
Michael Oldham
M.S.
Evaluation of office ETS exposure in relation to AB13
1999 (Cycle VIII)
$208,554
Lawrence Berkeley National Laboratory
William Fisk
B.S., M.S.
Smoking, Nicotine, Sleep & Mood in Normals & Depression
1995 (Cycle IV)
$207,434
University of California, San Diego
J. Christian Gillin
M.D.
Does nicotine increase sprouting of pericyte tubes?
2004 (Cycle XIII)
$207,300
La Jolla Institute for Molecular Medicine
Ugur Ozerdem
M.D.
Effects of Tobacco Taxation Upon Population Health Status
1997 (Cycle VI)
$206,547
University of California, San Diego
Robert Kaplan
Ph.D.
Environmental influences on tobacco use amg AAPI communities
2004 (Cycle XIII)
$204,722
Asian Pacific Partners for Empowerment Advocacy & Leadership
Rod Lew
MPH
Evaluating Mechanisms of Change in a Smoking Intervention
2008 (Cycle XVII)
$202,500
RAND Corporation
Harold Green
Ph.D.
Effects of exposure to secondhand smoke
1999 (Cycle VIII)
$194,404
Kaiser Foundation Research Institute
Carlos Iribarren
M.D., Ph.D., M.P.H.
Smoking, estrogen metabolites & cognitive function
2000 (Cycle IX)
$193,049
University of California, San Diego
Donna Kritz-Silverstein
Ph.D.
Ad and Movie Imagery and Teen's Perceptions About Smokers
1995 (Cycle IV)
$190,616
University of California, Irvine
Cornelia Pechmann
Ph.D.
Secondhand smoke promotes chemical toxicity in fetal lung
1997 (Cycle VI)
$190,536
University of California, Davis
Frederick Royce
M.D.
Genomics & transcriptome of oral precncr prgrssion in smkers
2004 (Cycle XIII)
$189,541
University of California, Los Angeles
Xiaofeng Zhou
Ph.D.
Novel Approaches to Lung Cancer Research
2006 (Cycle XV)
$189,486
The Burnham Institute for Medical Research
Kristiina Vuori
M.D., Ph.D.
Does nicotine exposure inhibit convective drug delivery ?
2007 (Cycle XVI)
$189,400
La Jolla Bioengineering Institute
Ugur Ozerdem
M.D.
Nicotine effects on neurological development
1999 (Cycle VIII)
$189,233
University of California, Irvine
Raju Metherate
Ph.D.
Assessing nicotine relapse in a mouse model
2001 (Cycle X)
$183,804
SRI International
Taline Khroyan
Ph.D.
Neurotoxic effects of nicotine: anatomy, mechanisms, effects
1999 (Cycle VIII)
$183,424
University of California, Los Angeles
Gaylord Ellison
Ph.D.
Role of Mast Cell Tryptase in Tobacco-Induced Carcinogenesis
1994 (Cycle III)
$175,409
Stanford University
Stephen Ruoss
M.D.
Recruitment of leucocytes to atherosclerotic lesions in vivo
2000 (Cycle IX)
$175,102
University of California, San Diego
Daniel Steinberg
M.D., Ph.D.
The eff of nicot on brain activity & neurocognition in schiz
2003 (Cycle XII)
$167,964
University of California, Irvine
Kirsten Fleming
Ph.D.
Will ApoE cause regression of atherosclerotic lesions?
1998 (Cycle VII)
$165,299
J. David Gladstone Institutes
Robert Pitas
Ph.D.
Effectiveness Evaluation of the I Decide Program
2006 (Cycle XV)
$162,304
University of Southern California
Louise Rohrbach
Ph.D., M.P.H.
Effects of tobacco-induced gamete damage on embryogenesis
2004 (Cycle XIII)
$158,853
Lawrence Livermore National Laboratory
Francesco Marchetti
Ph.D.
Human oocyte development and PAH exposure
2005 (Cycle XIV)
$158,556
Stanford University
Renee Reijo Pera
Ph.D.
Activation of Bnip3 in tobacco-induced heart disease
2005 (Cycle XIV)
$155,791
San Diego State University Research Foundation
Asa Gustafsson
Ph.D.
Mechanisms of Tobacco-Induced Retinal Neovascularization
2006 (Cycle XV)
$155,550
Stanford University
John Cooke
M.D., Ph.D.
Oxidative damage to sperm DNA: smoking and diet interaction
1998 (Cycle VII)
$155,135
University of California, Berkeley
Bruce Ames
Ph.D.
Tobacco radioactivity & public health policy
2005 (Cycle XIV)
$154,367
Cedars-Sinai Medical Center
Hrayr Karagueuzian
Ph.D.
The angiogenic role of interleukin-8 in lung cancer
2000 (Cycle IX)
$152,785
La Jolla Institute for Molecular Medicine
Ingrid Schraufstatter
M.D.
Effect of nicotine on fetal hemopoietic stem cell migration
2002 (Cycle XI)
$152,352
La Jolla Institute for Molecular Medicine
Sophia Khaldoyanidi
M.D., Ph.D.
Explaining racial differences in smoking
1999 (Cycle VIII)
$151,430
San Diego State University Research Foundation
Hope Landrine
Ph.D.
Tobacco-related cancer prevention by Vitamin A derivatives
1997 (Cycle VI)
$149,947
Molecular Medicine Research Institute
Marcia Dawson
Ph.D.
Environmental influences on tobacco use amg AAPI communities
2004 (Cycle XIII)
$149,610
CSU Fullerton Auxiliary Services Corporation
Sora Park Tanjasiri
DrPH, MPH
Nitric oxide-dependent cell signaling in vascular cells
2000 (Cycle IX)
$149,557
University of California, San Diego
Tanima Gudi
Ph.D.
Explaining racial differences in smoking
1999 (Cycle VIII)
$149,280
Public Health Foundation Enterprises, Inc.
Hope Landrine
Ph.D.
2-Xylosides Inhibit Glycolipid Synthesis and Cell Growth
1995 (Cycle IV)
$149,221
The Burnham Institute for Medical Research
Hudson Freeze
Ph.D.
Social Smoking within College Drinking Environments
2006 (Cycle XV)
$149,207
San Diego State University Research Foundation
Mark Reed
Ph.D.
Neuropharmacology of nicotine relapse
2003 (Cycle XII)
$149,175
Cedars-Sinai Medical Center
Xiu Liu
M.D., Ph.D.
The role of P450s in tobacco-mediated lung cancer
2001 (Cycle X)
$147,858
La Jolla Institute for Molecular Medicine
Scott Allen
M.S., Ph.D.
Chronic bronchitis: pathology of mucin gene expression
2000 (Cycle IX)
$147,758
University of California, San Francisco
Walter Finkbeiner
M.D., Ph.D.
Secondhand smoke contamination and resale value
2004 (Cycle XIII)
$146,760
San Diego State University Research Foundation
Georg Matt
Ph.D.
A novel lung tumor suppressor
1997 (Cycle VI)
$144,788
The Burnham Institute for Medical Research
Steven Frisch
Ph.D.
Toxic compounds targeted to lung tumor blood vessels
1998 (Cycle VII)
$144,300
The Burnham Institute for Medical Research
Erkki Ruoslahti
M.D., Ph.D.
Targeted Delivery of p53 to Lung Carcinoma Cells
1995 (Cycle IV)
$143,150
Sidney Kimmel Cancer Center
Ruth Gjerset
Ph.D.
Overcoming drug resistance in small cell lung cancer
2001 (Cycle X)
$141,340
The Burnham Institute for Medical Research
Kristiina Vuori
M.D., Ph.D.
Antiatherogenic helical segments of apo A-I
2004 (Cycle XIII)
$141,230
Lawrence Berkeley National Laboratory
John Bielicki
Ph.D.
Tobacco Use Among Hispanics in California
1994 (Cycle III)
$138,919
University of California, San Diego
Ana Navarro
Ph.D.
Nicotine modifies cardiac growth during adolescence
2007 (Cycle XVI)
$138,600
Veterans Medical Research Foundation
Wilbur Lew
M.D.
Investigating College Student Cigarette Smoking Self-change
2007 (Cycle XVI)
$138,596
Veterans Medical Research Foundation
Mark Myers
Ph.D.
Evaluation of ad strategies for preventing youth tobacco use
1997 (Cycle VI)
$136,953
University of California, Irvine
Cornelia Pechmann
Ph.D.
A mindfulness-based approach to relapse prevention
2005 (Cycle XIV)
$134,325
California Pacific Medical Center Research Institute
Cassandra Vieten
Ph.D.
Activation of Bnip3 in tobacco-induced heart disease
2005 (Cycle XIV)
$134,074
Scripps Research Institute
Asa Gustafsson
Ph.D.
Pediatrician training to prevent children's tobacco exposure
1997 (Cycle VI)
$133,852
University of California, San Francisco
Eliseo Perez-Stable
M.D.
Nicotine Disrupts PTHrP-Driven Paracrine Signaling Globally
2006 (Cycle XV)
$133,126
LA Biomedical Research Institute at Harbor-UCLA Medical Center
Virender Rehan
M.D.
Oxidative damage to sperm DNA: smoking and diet interaction
1998 (Cycle VII)
$132,367
Children's Hospital Oakland Research Institute
Bruce Ames
Ph.D.
The effect of nicotine and cigarette smoke on respiration
1998 (Cycle VII)
$130,177
Scripps Research Institute
Merrill Mitler
Ph.D.
Instant SHS Feedback as a Catalyst for Smoke-Free Homes
2008 (Cycle XVII)
$129,917
San Diego State University Research Foundation
Neil Klepeis
Modeling cost/effectiveness of tobacco control programs
2002 (Cycle XI)
$129,915
University of California, San Diego
Robert Kaplan
Ph.D.
Prenatal smoke exposure and age at Menarche
2002 (Cycle XI)
$129,090
Sequoia Foundation
Gayle Windham
Ph.D.
Regulation of a novel airway glandular mucin by smoke
2004 (Cycle XIII)
$126,126
University of California, Davis
Yin Chen
Ph.D.
California pharm-assists for smoking cessation
1999 (Cycle VIII)
$124,689
SRI International
Karen Hudmon
Dr.P.H., R.P.H., M.S.
California pharm-assists for smoking cessation
1999 (Cycle VIII)
$124,689
SRI International
Marilyn Shreve
R.Ph.
Plasma antioxidant enzymes as markers of smoke injury
1997 (Cycle VI)
$123,073
Lawrence Berkeley National Laboratory
Trudy Forte
Ph.D.
Lifetime passive smoke exposure and breast cancer in the CTS
2004 (Cycle XIII)
$122,659
Public Health Institute
Peggy Reynolds
Ph.D.
Tobacco Products, Activin-A, and Lung Cancers
1995 (Cycle IV)
$122,583
University of Southern California
Shao-Yao Ying
Ph.D.
Understanding and preventing college smoking
2000 (Cycle IX)
$122,377
University of Southern California
Donna Spruijt-Metz
Ph.D.
Discovery of serum markers of lung cancer
1998 (Cycle VII)
$120,300
Cedars-Sinai Medical Center
Phillip Koeffler
M.D.
Nicotine & cardiac vulnerability to fibrillation
2000 (Cycle IX)
$120,000
Cedars-Sinai Medical Center
Hrayr Karagueuzian
Ph.D.
Neurobehavioral consequences of adolescent nicotine exposure
2000 (Cycle IX)
$120,000
Scripps Research Institute
Cindy Ehlers
Ph.D.
Smoking, breast cancer and tobacco metabolizing genes
1999 (Cycle VIII)
$120,000
Childrens Hospital, Los Angeles
Jan Van Tornout
M.D., M.S.
Smoking and echogenicity of the arterial intima
2000 (Cycle IX)
$119,299
University of Southern California
James Dwyer
Ph.D.
Computer Simulation as a Tool for Reducing SHS Exposure
2007 (Cycle XVI)
$118,418
Education Training and Research Associates, Inc.
Neil Klepeis
Effect of tobacco smoke on lung airway surface liquid
1998 (Cycle VII)
$115,658
Children's Hospital Oakland Research Institute
Jacob Bastacky
M.D.
Genetic links to nicotine addiction: ethics of testing teens
1999 (Cycle VIII)
$115,591
Stanford University
Thomas Raffin
M.D.
Brain wave assessment of tobacco cessation readiness
1997 (Cycle VI)
$115,487
Scripps Research Institute
Aaron Ilan
Ph.D.
Effects of tobacco smoke exposure on hormones and fertility
1998 (Cycle VII)
$115,335
Sequoia Foundation
Gayle Windham
Ph.D.
African American church role in tobac